BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//hacksw/handcal//NONSGML v1.0//EN
BEGIN:VEVENT
UID:af60419669e5d6fe6fc114c8d8bbc2b7
DTSTAMP:20260404T040130Z
DTSTART:20201020T193000
DTEND:20201020T200000
SUMMARY:TechNet Conference: An introduction to VIPS (Vaccine Innovation Prioritisation Strategy) - outcomes of the prioritization process and next steps
DESCRIPTION:The Vaccine Innovation Prioritisation Strategy (VIPS) represents an unprecedented three-year collaboration between the Gavi Secretariat, World Health Organization (WHO), Bill & Melinda Gates Foundation (BMGF), United Nations Children’s Fund (UNICEF) and PATH – known as the VIPS Alliance - to develop a single integrated framework to evaluate and prioritise innovations in vaccine product delivery that meet country needs. The goal of VIPS is to provide greater clarity to manufacturers and partners to inform and influence investment decisions, and to drive these innovations forward. This presentation will discuss the prioritisation process, the 3 prioritised innovations / approaches and the proposed next steps to advance them.\nPresenters: Gitte Giersing (WHO), Marion Menozzi-Arnaud (Gavi) \n
X-ALT-DESC;FMTTYPE=text/html:\n\n\n\n\n\n\n\n\nThe Vaccine Innovation Prioritisation Strategy (VIPS) represents an unprecedented three-year collaboration between the Gavi Secretariat, World Health Organization (WHO), Bill & Melinda Gates Foundation (BMGF), United Nations Children’s Fund (UNICEF) and PATH – known as the VIPS Alliance - to develop a single integrated framework to evaluate and prioritise innovations in vaccine product delivery that meet country needs. The goal of VIPS is to provide greater clarity to manufacturers and partners to inform and influence investment decisions, and to drive these innovations forward. This presentation will discuss the prioritisation process, the 3 prioritised innovations / approaches and the proposed next steps to advance them.
Presenters: Gitte Giersing (WHO), Marion Menozzi-Arnaud (Gavi)
\n\n\n
LOCATION:
END:VEVENT
END:VCALENDAR